Food / Nutrition apps and supplement companies use our biotech to advise and match products with actual physiological needs and measure if those products work. At Sahha.ai we capture biomarkers from smartphones and wearables. We provide easy access to sleep patterns, stress levels, activity data, trends and insights with our intelligence layer. These are some examples I've seen of how some of our partners have used our data; - Poor sleep patterns trigger targeted nutrition advice. Apps recommend magnesium-rich foods and earlier carb intake. Supplement companies suggest melatonin for sleep latency or magnesium for frequent awakenings. - High activity users receive protein and BCAA recommendations timed to post-workout windows. Recovery speeds validate if supplementation is adequate. - Low activity + poor sleep prompts specific nutritional guidance - foods higher in vitamin D in the morning and B-complex recommendations for energy support. - Stress patterns detected through HRV lead to adaptogen suggestions like ashwagandha or rhodiola. Food apps prioritize anti-inflammatory options. Nutrition platforms recommend omega-3s and magnesium during sustained stress periods. By using our behavioural archetypes and health insights, supplement companies can better recommend products and retain customers. Food apps suggest optimal foods with perfectly timed notifications. Nutrition apps provide personalised advice and demonstrate if recommendations actually make a difference. This seems to be extremely effective as partners report greatly improved customer retention and increased conversions when targeting health states. I'm excited to see greater development in how these companies generate reports from population trends. For users, it's powerful when an app measurably shows that active hours have increased or sleep quality has improved over time. It's fascinating to watch our partners use this data to identify which nutraceuticals work best for specific health demographics. With our behavioural archetype system, we track if someone becomes more active, if sleep habits shift, or if mental wellbeing improves from biomarker data. This health information enhances sales but more importantly improves quality of life by advising optimal nutrition choices for specific health states AND showing results. With readily available biomarkers our intelligence layer transforms nutrition from reactive supplementation to proactive health optimisation.
Founder and CEO / Health & Fitness Entrepreneur at Hypervibe (Vibration Plates)
Answered 5 months ago
When people think "biotech in food," they jump to CRISPR-edited crops or lab-grown steak. But one of the most underappreciated frontiers isn't just improving the food—it's upgrading the body that eats it. I've worked extensively with vibration therapy platforms originally built for aerospace medicine. Today, we're using them in everyday settings to amplify how the human body extracts and uses nutrients. Think of it as a mechanical boost to metabolic efficiency. Whole-body vibration (WBV) activates deep muscle contractions, enhances glucose uptake through GLUT-4 transporters, and stimulates the release of powerful myokines like irisin and BDNF. These act like natural, biotech-produced supplements—improving fat burning, appetite control, and even mood. Vibration also increases microcirculation and lymphatic flow, which means nutrients get delivered faster and waste gets cleared more efficiently. In practice, I've seen WBV help clients—from athletes to busy parents—get more from the same meals. Better protein synthesis, improved calcium uptake, and even enhanced gut motility all translate into better nutrient absorption without changing what's on the plate. What's next? I see a future where mechanotherapy meets nutrigenomics. Picture your smartwatch recommending 6 minutes on a vibration platform after a salmon lunch to optimize omega-3 uptake. It sounds wild, but early studies already show vibration alters insulin sensitivity and lipid metabolism. That's the kind of biotech that won't just feed more people—it'll help them get more out of every bite.
I once helped a client source components for a hydroponic setup that used biotech enzymes to speed plant growth. It wasn't big science, just small tweaks that helped vegetables grow faster with less water. Watching that system work made me realize biotech isn't far from sourcing—it's about efficiency. The farmers saved around 20 percent on input costs within a season. What I see coming next is food labs built right into farms, testing nutrition on the spot instead of shipping samples away. That kind of speed will change how producers plan harvests and control quality worldwide.
In my work covering food systems and sustainability, I've seen how biotechnology is being leveraged to improve both production efficiency and nutritional outcomes. One practical example is the use of precision fermentation to create proteins and enzymes that traditionally come from animals. This not only reduces the environmental footprint of food production but also ensures a more stable supply chain, less vulnerable to disease outbreaks or climate shocks. On the nutrition side, biotech has enabled the development of biofortified crops—for instance, rice enriched with Vitamin A or wheat varieties with higher iron content. These innovations directly address micronutrient deficiencies in populations where supplementation is limited, making nutrition more accessible through everyday diets. What excites me most about the future is the potential of bioreactor-grown ingredients at scale. Companies are already producing dairy proteins, egg whites, and even fats through microbial fermentation, with taste and functionality nearly identical to their conventional counterparts. As McKinsey recently noted, this could become a $100-150 billion market opportunity in the next decade, fundamentally reshaping how we think about protein and ingredient sourcing. The ripple effect is enormous: lower greenhouse gas emissions, reduced land and water use, and healthier, more resilient food systems. The challenge will be scaling production affordably and ensuring consumer trust through transparency and regulation. The takeaway: biotech is not just about novelty—it's about building a food system that is more sustainable, nutritious, and resilient for the future.
Biotech has made it easier to improve food quality without relying on heavy chemicals. Things like lab-grown proteins and better crop engineering are already changing the game. I think the most exciting part is how it could make healthier options more affordable and available to more people.
Biotechnology has revolutionized agriculture by enhancing food production and nutritional quality through tools like genetic engineering and microbial technologies. A notable example is Golden Rice, genetically modified to contain beta-carotene, which addresses vitamin A deficiency in developing countries. This rice variant presents a sustainable solution to malnutrition, particularly for vulnerable populations.
Being the Founder and Managing Consultant at spectup, I have seen firsthand how biotech innovations can transform food production and nutrition, especially for startups looking to scale efficiently. One example involved a client working on precision fermentation to create protein-rich ingredients for plant-based foods. Their challenge was producing consistent, nutrient-dense outputs at scale while keeping costs manageable. By leveraging biotech solutions, such as engineered microbes and optimized fermentation processes, they were able to increase yield, enhance nutrient profiles, and maintain flavor integrity. It was fascinating to watch a small lab-based idea translate into scalable production with measurable impact. What made the approach particularly effective was integrating data-driven monitoring throughout the production process. Sensors and AI models allowed the team to adjust parameters in real time, minimizing waste and ensuring consistent quality. From a consultancy perspective, this was not just a technical achievement—it also strengthened their investor readiness. We helped position the company as both innovative and operationally capable, which made a significant difference during funding discussions. Looking ahead, one exciting development I foresee is the convergence of biotechnology with personalized nutrition. Startups are exploring ways to tailor functional foods to individual genetic and microbiome profiles. Imagine a product line that adapts nutrient content based on the consumer's specific needs, supported by scalable biotech production. This level of customization could redefine dietary health while creating new investment opportunities. At spectup, we often advise growth-stage companies to focus not only on technology but also on market applicability and storytelling. Biotech in food is not just about science; it is about creating solutions that matter to people, attract investment, and enable sustainable growth, which is the type of innovation I find most compelling.